E-Mail IMAGE: A heavy layer of glycans, seen here in green, cover immune cells and provide a way to target cancer-specific markers in the body. view more Credit: Image courtesy of Senlian Hong, Wu Lab at Scripps Research LA JOLLA, CA--Scientists at Scripps Research have demonstrated a promising new strategy for treating lymphomas, a group of cancers that begin in infection-fighting cells of the immune system called lymphocytes. The new approach uses natural cancer-targeting immune cells, known as natural killer cells, that have been modified to selectively target lymphoma. As desc...